Stock Events

Perspective Therapeutics 

$1.07
22
-$0.09-7.76% Friday 20:00

Statistics

Day High
1.29
Day Low
1.05
52W High
1.91
52W Low
0.21
Volume
8,605,609
Avg. Volume
7,091,407
Mkt Cap
666.21M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

14MayConfirmed
Q4 2023
Q1 2024
-0.03
-0.03
-0.03
-0.02
Expected EPS
-0.02177108898
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CATX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Analyst Ratings

2.1$Average Price Target
The highest estimate is $3.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

About

Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.
Show more...
CEO
Lori Woods
Employees
116
Country
US
ISIN
US46489V1044
WKN
000A0MQNM

Listings